Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization

NCT06229080 is registered in ClinicalTrials.gov with Next Biomedical Co., Ltd. as lead sponsor.

NCT NCT06229080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06229080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization
Lead sponsor
Next Biomedical Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2023
Completion date
July 30, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer (primary and metastatic)